Activation of immune blood biomarkers from interferon gamma pathway distinguished long-term survivors (>=2 years) ...
Explore types of U.S. work visas, application steps, rights and responsibilities for foreign workers. Learn how to live and ...
By Kenna Jenkins, February 3, 2026 Multiple universities in California, including three California State Universities, have been recognized as Black-Serving Institutions under a new state-wide ...
India Post has opened applications for Gramin Dak Sevak recruitment 2026 to fill 28,740 vacancies across 23 postal circles. The recruitment covers BPM, ABPM and GDS posts and follows a merit-based ...
OS Animal Health (OSAH), a wholly owned OS Therapies (OSTX) subsidiary, targets an IPO on NYSE American or Nasdaq ...
Confirmation Received from MHLW That QRX003 Qualifies for Both Orphan Drug Designation and Fast Track Regulatory Review Status. Quoin Initiating the Establishment of a Japanese Su ...
ASHBURN, Va., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (“Quoin” or the “Company”), a late clinical-stage specialty pharmaceutical company focused on rare and orphan ...
If granted, QRX003 could be approved for sale and reimbursement in Saudi Arabia as a treatment for Netherton Syndrome in 2H 2026 QRX003 could become the first ever approved treatment for Netherton ...
QRX003 could become the first ever approved treatment for Netherton Syndrome ASHBURN, Va., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (“Quoin” or the “Company”), a ...
QRX003 could become the first ever approved treatment for Netherton Syndrome ASHBURN, Va., Jan. 20, 2026 (GLOBE NEWSWIRE) — Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (“Quoin” or the “Company”), a late ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results